Stephen Chorney
Assistant Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (19)
Objective To determine the frequency of aspiration resolution after recurrent laryngeal nerve (RLN) reinnervation among children with dysphagia. Study Design Case series with chart review. Methods All pediatric RLN reinnervations between January 2013 and December 2022 at a tertiary aerodigestive program were included. Only children completing video fluoroscopic swallow studies (VFSS) prior to the RLN procedure were analyzed. Postoperative outcomes included swallowing function from VFSS, including thin liquid aspiration. Results Twenty‐four RLN reinnervations were reviewed, with six children obtaining both preoperative and postoperative VFSS. Following RLN reinnervation, no patients were noted to aspirate, and all patients had advancement in their diet consistencies. Conclusions Resolution of dysphagia and advancement of the oral diet after RLN reinnervation is common among children with aspiration and unilateral vocal fold immobility. Long‐term improvement of swallowing function in children with unilateral vocal cord paralysis corrected by RLN reinnervation must be examined further. Level of Evidence 4.
Year:
2025
Objective The objective of this study is to determine the impact of an intensive and a less intensive speech therapy regimen on pediatric sialorrhea patient and caregiver quality of life (QoL) as described by drooling impact scales (DIS). Methods A retrospective chart review included all pediatric patients from a secretion management clinic. There were two outpatient speech therapy programs: intensive (4 sessions/week for 3 weeks) and less intensive (2 sessions/week for 3 months). Both regimens included similar interventions including neuromuscular electrical stimulation and facial taping. The primary outcome measure was reduction in caregiver reported DIS after completing their designated program. Children observed without therapy also obtained DIS assessments overtime to measure potential changes in QoL. Results There were 49 patients included in the study with a mean age of 7.5 years (SD = 4.6). The most common comorbidities were global developmental delay ( n = 47; 96%), epilepsy ( n = 35; 71%), and cerebral palsy ( n = 32; 65%). After initial evaluation, 30 patients underwent speech therapy with significantly improved DIS scores compared to the 19 who had no therapy (43.4 vs. 54.5, p = 0.03). Of these 30, 16 (33%) underwent intensive therapy with mean DIS improving from 63.5 to 47.2 ( p = 0.006). Fourteen (29%) completed the less intensive regimen with mean DIS improving from 51.9 to 39.1 ( p = 0.07). There were 19 (39%) patients who underwent no therapy and mean DIS remained unchanged from 55.6 to 54.5 ( p = 0.86). Conclusion Sialorrhea can drastically impact patients and their families. An intensive speech therapy program is associated with improved QoL as described by the DIS. Speech therapy should be considered as an effective treatment modality to improve outcomes for pediatric sialorrhea. Level of Evidence 2.
Year:
2025
Objective To estimate the incidence and identify predictors of pediatric tracheostomy patients who transition into adulthood with a tracheostomy. Methods We conducted a retrospective analysis of pediatric tracheostomy patients treated at a single tertiary care pediatric hospital between 2009 and 2022. Patient demographics, comorbidities, tracheostomy outcomes, including decannulation and mortality rates, and the status of those alive with a tracheostomy at adulthood were compared. Results Of the 663 children who underwent a tracheostomy, 103 (15.5%) would have surpassed 18 years by September 1, 2023. Detailed breakdown: 26 (25%) were alive with a tracheostomy, 35 (34%) had been decannulated, 25 (24%) had passed away, and 17 (16.5%) were lost to follow‐up. Patients who retained their tracheostomies into adulthood were more likely to be older at tracheostomy placement (mean age 14.3 vs. 1.7 years, p < 0.001), Hispanic (43.7% vs. 30.5%, p = 0.003), not ventilated at initial discharge (41% vs. 24%, p < 0.001), and have severe neurocognitive disabilities (72% vs. 53%, p < 0.001). Logistic regression identified older age at tracheostomy placement (OR = 1.35, 95% CI [1.24–1.48]) and severe neurocognitive disability (OR = 6.20, 95% CI [2.13–18.09]) as significant predictors of maintaining a tracheostomy into adulthood. Conclusions Older age at tracheostomy placement and severe neurocognitive disabilities significantly predict the transition of pediatric tracheostomy patients to adult care with their tracheostomies. These findings highlight the need for specialized transition programs tailored to the needs of this unique population. Level of Evidence 4 Laryngoscope , 135:1186–1191, 2025
Year:
2024
Introduction In pediatric tonsillectomy management, the consistent tracking of surgical outcomes and adherence to guidelines are vital. This study explores how a surgical dashboard can serve as a tool in research analysis, translating AAO‐HNSF guidelines into measurable performance improvements. Methods Using a prospective registry from three pediatric hospitals, a Tableau dashboard was constructed to graphically visualize key demographic and postoperative outcomes (including intensive care unit [ICU] utilization, 30‐day emergency department (ED) visits, and postoperative bleed rates) in children undergoing tonsillectomy from 2020 to 2024. From the dashboard data, a retrospective cohort study analyzing 6767 tonsillectomies was conducted from January 2, 2020, to June 20, 2023. Patients were categorized into low‐risk, OSA‐only (by ICD‐10 codes), and high‐risk groups based on comorbidities. Logistic regression identified factors influencing ED revisits and unplanned nursing calls. Three quality initiatives were assessed: preoperative school absence notes, perioperative dexamethasone recording, and post‐tonsillectomy parental education. Results A total of 2122 (31%) were low‐risk, 2648 (39%) were OSA‐only, and 1997 (30%) high risk. Risk factors that increased the likelihood of ED visits were high‐risk comorbidities (OR = 1.46; 95% CI = 1.24–1.74; p < 0.001) and older age (OR = 1.05; 95% CI = 1.03–1.08; p < 0.001). Risk factors that increased the likelihood of an unplanned nursing communication were high‐risk comorbidities (OR = 1.53; 95% CI = 1.34–1.75; p < 0.001), older age (OR = 1.03, 95% CI = 1.01–1.04; p = 0.001), and Medicaid insurance (OR = 1.25; 95% CI = 1.09–1.43; p = 0.002). Postoperative bleed control was generally comparable between the groups, at 2.8% (low risk), 2.7% (OSA), 3.2 (high risk) ( p = 0.651). Conclusion The dashboard aided in data collection, data visualization, and data analysis of quality improvement initiatives, effectively translating guidelines into tangible measures to enhance care. Level of evidence NA.
Year:
2024
Objectives The objective of this study is to determine the time to ventilator liberation and decannulation after tracheostomy placement in children with bronchopulmonary dysplasia (BPD) and pulmonary hypertension. Methods A prospective cohort study included all children (<18 years old) who underwent tracheostomy between 2015 and 2021 with or without a diagnosis of BPD. The primary outcomes were time to ventilator liberation, tracheostomy decannulation, or death with tracheostomy in place. Results A total of 303 children met inclusion with a median (interquartile range [IQR]) age at tracheostomy of 6.9 (IQR: 4.0–49.5) months. A diagnosis of BPD was made for 42% ( N = 127) and this group was younger (5.1 vs. 24.5 months, p < .001) and more often had pulmonary hypertension (68% vs. 24%, p < .001). Children with BPD spent a median of 2.9 years (IQR: 1.6–4.0) on ventilation compared to 1.9 years (IQR: 0.9–3.7) for children without BPD ( p = .009). The time to decannulation was greater among children with BPD (3.4 vs. 1.8 years, p < .001). However, unadjusted estimates of ventilator liberation (hazard ratio [HR]: 1.05, 95% confidence interval [95% CI]: 0.77–1.44) and decannulation (HR: 1.11, 95% CI: 0.74–1.66) over time were not prolonged by BPD. Pulmonary hypertension was associated with shorter time to death (adjusted HR [aHR] = 1.99, 95% CI: 1.17–3.38, p = .01), while BPD was associated with longer time to death (aHR: 0.38, 95% CI: 0.22–0.67, p = .001). Conclusion BPD is associated with increased ventilation and duration of tracheostomy but over time many children with BPD will wean off the ventilator and be decannulated. Pulmonary hypertension and not BPD is associated with increased time to death after tracheostomy.
Year:
2024
Objectives To determine the incidence of subglottic stenosis (SGS) in children after tracheostomy and identify risk factors for development. Study Design Retrospective cohort. Methods All patients (<18 years) undergoing tracheostomy at a tertiary children's hospital between 2015 and 2020 were included. Patients with a direct laryngoscopy (DL) concurrent with tracheostomy and a subsequent DL were included. Medical records, including operative reports, were reviewed to identify subglottic stenosis and associated risk factors. Results A total of 140 patients were included with mean age at tracheostomy of 2.4 years (standard deviation [SD]: 4.3) (median: 0.5 years, interquartile range [IQR]: 0.3–1.5 years) and gestational age of 33.8 weeks (SD: 5.9) (median: 36 weeks, IQR: 28–39 weeks). At initial DL, 24% ( N = 34) had subglottic injury and 26% ( N = 37) developed SGS. The incidence of SGS after tracheostomy was 11.5 cases per 100 patients per year. At tracheostomy, lower birth weight (1.8 vs. 2.3 kg, p = 0.005), shorter gestational age (31.8 vs. 34.6 weeks, p = 0.01), younger age (0.8 vs. 2.9 years, p = 0.01), lower weight (5.8 vs. 14.7 kg, p = 0.01), and subglottic injury (44% vs. 21%, p = 0.01) were associated with the development of SGS. Multivariable logistic regression analysis associated birth weight (odds ratio [OR]: 0.49, 95% confidence interval [CI]: 0.31–0.75, p = 0.001) and early subglottic injury (OR: 3.22, 95% CI: 1.31–7.88, p = 0.01) with SGS development. Conclusions The incidence of SGS after pediatric tracheostomy is estimated at 11.5 cases per 100 patients per year. Low birth weight and subglottic injury at the time of tracheostomy were associated with SGS in this vulnerable population of children. Level of Evidence 3 Laryngoscope , 2024
Year:
2024
Objective To determine whether injection laryngoplasty (IL) resolves thin liquid aspiration among children with unilateral vocal cord paralysis (UVCP) after cardiac surgery. Study Design Retrospective case‐control. Setting Tertiary children's hospital. Methods Consecutive children (<5 years) between 2012 and 2022 with UVCP after cardiac surgery were included. Resolution of thin liquid aspiration after IL versus observation was determined for children obtaining videofluoroscopic swallow studies (VFSS). Results A total of 32 children with left UVCP after cardiac surgery met inclusion. Initial surgeries were N = 9 (28%) patent ductus arteriosus ligations, N = 7 (22%) aortic arch surgeries, N = 9 (28%) surgeries for hypoplastic left heart syndrome, and N = 7 (22%) other cardiac surgeries. The mean age at initial surgery was 1.8 months (SD: 3.7). All children had a VFSS obtained after surgery that confirmed aspiration. There were 17 children that obtained an IL at 33.6 months (SD: 20.9) after cardiac surgery and 15 children observed without IL procedure. No surgical complications after IL were noted. The rate of aspiration resolution based on postoperative VFSS was N = 14 (82%) for the IL group and N = 9 (60%) for the control group P = .24. Documented VFSS aspiration resolution after cardiac surgery occurred by 9.6 months (SD: 10.0) in the observation group and 47.4 months (SD: 24.1) in the IL group ( P < .001). Conclusion IL can help treat aspiration in children with UVCP after cardiac surgery but the benefit beyond observation remains unclear. Future studies should continue to explore the utility for IL in managing dysphagia in this pediatric population.
Year:
2024
Objectives : To determine the time to ventilator liberation and decannulation after tracheostomy placement in children with bronchopulmonary dysplasia (BPD) and pulmonary hypertension. Methods: A prospective cohort study included all children (<18 years old) who underwent tracheostomy between 2015 and 2021 with or without a diagnosis of BPD. The primary outcome measures were times to mechanical ventilator liberation, tracheostomy decannulation, or death with tracheostomy in place. Patient demographics, associated comorbidities, and outcomes were compared between groups. Results: A total of 318 children met inclusion with a median (interquartile, IQR) age at tracheostomy of 6.9 (IQR: 4.1 – 49.2) months and 54% (N=170) were male. A diagnosis of BPD was made for 43% (N=136) and this group was younger at tracheostomy placement (5.2 vs. 24.5 months, P <.001) and more often had pulmonary hypertension (65% vs. 24%, P <.001) than children without BPD. Children with BPD spent a median of 2.92 years (IQR: 1.60 – 4.03) on mechanical ventilation compared to 1.84 years (IQR: 0.84 – 3.60) for children without BPD ( P =.003). Unadjusted estimation of time to decannulation was longer for children with BPD (HR=0.92, 95% CI: 0.62 – 1.38). The adjusted survival analysis for time to mortality included pulmonary hypertension as a variable of significance (aHR= 2.5, 95% CI: 1.43 – 4.40). Conclusion : The presence of BPD is associated with an increased duration of mechanical ventilation and time to tracheostomy decannulation. Pulmonary hypertension is associated with an increased mortality risk among this vulnerable population of children.
Year:
2024
Objective This study aimed to determine the direct costs of pediatric tracheostomy care within a health care system. Study Design Prospective analysis. Setting Academic children's hospital. Methods Costs associated with caring for pediatric tracheostomy patients under 18 years were analyzed between 2015 and 2021. Direct costs were calculated using the Medicare/Medicaid charges‐to‐costs ratio for various visit types. Costs were estimated using generalized linear equations, accounting for confounders. Results A total of 297 children underwent tracheostomy at a median age of 0.94 years. The median follow‐up was 2.5 years, resulting in 13,966 visits (mean = 41). The total cost was $321 million. The initial admission accounted for 72% ($231 million) of costs while other inpatient admissions added 24% ($78 million). Emergency department, observation, and outpatient visits comprised 4% of costs. The length of stay (LOS) was the primary cost driver for inpatient visits. Each additional hospital day increased costs by roughly $1195, and each extra admission added about $130,223 after adjusting for confounders. Respiratory failure and infections were the primary reasons for 67% of subsequent admissions. Conclusion Pediatric tracheostomy care generated over $300 million in direct costs over 5 years. Inpatient stays constituted 96% of these costs, with the LOS being a major factor. To reduce direct health expenditures for these patients, the focus should be on minimizing admissions.
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Collaborators (3)
Romaine Johnson
MD/MPH Program Director
University of Texas Southwestern Medical Center
Yann‐Fuu Kou
Assistant Professor
-
Ron Mitchell
-
Make your next move.
Prepare your application
Review drafts before you send them.